Evidence map›Paper›PMID 34272705›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Sources of Interindividual Variability.

Yvonne S Lin, Kenneth E Thummel, Brice D Thompson, Rheem A Totah, Christi W Cho

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yvonne S LinDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA. yvonlin@uw.edu.
Kenneth E ThummelDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Brice D ThompsonDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Rheem A TotahDepartment of Medicinal Chemistry, University of Washington, Seattle, WA, USA.
Christi W ChoDepartment of Medicinal Chemistry, University of Washington, Seattle, WA, USA.

Funding

Building Research across Interdisciplinary Gaps (BRIDG) T90/R90 Training ProgramT90AT008544 · NCCIH · UNIVERSITY OF WASHINGTON · PI BOOTH-LAFORCE, CATHRYN, BRADLEY, RYAN D · 2015 to 2023
$3.9M
NCCIH NIH HHS T90 AT008544
6 · The paper itself

Abstract

The efficacy, safety, and tolerability of drugs are dependent on numerous factors that influence their disposition. A dose that is efficacious and safe for one individual may result in sub-therapeutic or toxic blood concentrations in others. A significant source of this variability in drug response is drug metabolism, where differences in presystemic and systemic biotransformation efficiency result in variable degrees of systemic exposure (e.g., AUC, C

Indexed as

Pharmacogenomic VariantsBiotransformationCytochrome P450 Family 4Gene Expression RegulationHumansInactivation, MetabolicPharmaceutical PreparationsPrecision MedicineCytochrome P450 Family 4Pharmaceutical PreparationsDiseaseGenderInterindividual variabilityPharmacogenomicsPregnancy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.